{"brief_title": "Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)", "brief_summary": "The purpose of this study is to determine the effect of montelukast, an approved medication, on the lower leg growth rate in children with mild asthma. The primary hypothesis is that the lower leg length (LLL) growth rate for children treated with montelukast compared to placebo will be established.", "detailed_description": "This is a crossover study that consists of a 2-week placebo run-in period, then a first 3-week treatment period, then a 2-week washout period, and then a second 3-week treatment period. Participants will be randomized to treatment with either montelukast and placebo or budesonide and placebo. The duration of treatment is 6 weeks.", "condition": ["Asthma, Bronchial"], "intervention_type": ["Drug", "Drug", "Drug", "Drug"], "intervention_name": ["Montelukast chewable tablets", "Budesonide inhaler", "Placebo to montelukast chewable tablets", "Placebo to budesonide inhaler"], "description": ["Montelukast sodium 5 mg chewable tablets", "Budesonide 200 mcg inhalation powder", "Placebo chewable tablets", "Placebo inhalation powder"], "arm_group_label": ["Montelukast\u2192Placebo", "Placebo\u2192Montelukast", "Budesonide\u2192Placebo", "Placebo\u2192Budesonide", "Montelukast\u2192Placebo", "Placebo\u2192Montelukast", "Budesonide\u2192Placebo", "Placebo\u2192Budesonide"], "criteria": "Inclusion Criteria: - A 6-month history of asthma with periodic episodes requiring treatment. Exclusion Criteria: - Medical history of a lung disorder (other than asthma) or a recent upper respiratory tract infection.", "gender": "All", "minimum_age": "6 Years", "maximum_age": "11 Years", "healthy_volunteers": "No", "mesh_term": ["Asthma", "Budesonide", "Montelukast"], "id": "NCT00092092"}